Pfe) and opko health inc Opk) announced today that the u.s Read important safety & prescribing info. Fda approved sogroya (somapacitan) on august 28 for adults with growth hormone deficiency Sogroya is the first human growth hormone (hgh) therapy that adult patients only take once a week Please see full prescribing and safety information.
Lonapegsomatropin (approved by the fda in 2021 for the treatment of pediatric ghd) is a prodrug of somatropin (human growth hormone, or hgh) administered once weekly, providing sustained release of active, unmodified somatropin.
OPEN
